[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Anti-Inflammatory Drugs (NSAIDs) Market Report 2017

December 2017 | 96 pages | ID: UF336411C89EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Anti-Inflammatory Drugs (NSAIDs) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Anti-Inflammatory Drugs (NSAIDs) in these regions, from 2012 to 2022 (forecast).
United States Anti-Inflammatory Drugs (NSAIDs) market competition by top manufacturers/players, with Anti-Inflammatory Drugs (NSAIDs) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AbbVie
  • Amgen
  • AstraZeneca
  • Eli Lily
  • GlaxoSmithKline
  • Roche
  • Johnson & Johnson
  • Merck
  • Novartis
  • Pfizer
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Anti-inflammatory Biologics
  • Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hosptical
  • Pharmacy
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Anti-Inflammatory Drugs (NSAIDs) Market Report 2017

1 ANTI-INFLAMMATORY DRUGS (NSAIDS) OVERVIEW

1.1 Product Overview and Scope of Anti-Inflammatory Drugs (NSAIDs)
1.2 Classification of Anti-Inflammatory Drugs (NSAIDs) by Product Category
  1.2.1 United States Anti-Inflammatory Drugs (NSAIDs) Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Anti-Inflammatory Drugs (NSAIDs) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Anti-inflammatory Biologics
  1.2.4 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  1.2.5 Corticosteroids
  1.2.6 Others
1.3 United States Anti-Inflammatory Drugs (NSAIDs) Market by Application/End Users
  1.3.1 United States Anti-Inflammatory Drugs (NSAIDs) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hosptical
  1.3.3 Pharmacy
  1.3.4 Other
1.4 United States Anti-Inflammatory Drugs (NSAIDs) Market by Region
  1.4.1 United States Anti-Inflammatory Drugs (NSAIDs) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2012-2022)
  1.4.3 Southwest Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2012-2022)
  1.4.5 New England Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2012-2022)
  1.4.6 The South Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2012-2022)
  1.4.7 The Midwest Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anti-Inflammatory Drugs (NSAIDs) (2012-2022)
  1.5.1 United States Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2022)
  1.5.2 United States Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anti-Inflammatory Drugs (NSAIDs) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anti-Inflammatory Drugs (NSAIDs) Average Price by Players/Suppliers (2012-2017)
2.4 United States Anti-Inflammatory Drugs (NSAIDs) Market Competitive Situation and Trends
  2.4.1 United States Anti-Inflammatory Drugs (NSAIDs) Market Concentration Rate
  2.4.2 United States Anti-Inflammatory Drugs (NSAIDs) Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTI-INFLAMMATORY DRUGS (NSAIDS) SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Region (2012-2017)
3.2 United States Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Region (2012-2017)
3.3 United States Anti-Inflammatory Drugs (NSAIDs) Price by Region (2012-2017)

4 UNITED STATES ANTI-INFLAMMATORY DRUGS (NSAIDS) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type (2012-2017)
4.3 United States Anti-Inflammatory Drugs (NSAIDs) Price by Type (2012-2017)
4.4 United States Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTI-INFLAMMATORY DRUGS (NSAIDS) SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Application (2012-2017)
5.2 United States Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTI-INFLAMMATORY DRUGS (NSAIDS) PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AbbVie
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbVie Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Amgen
  6.2.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Amgen Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 AstraZeneca
  6.3.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Eli Lily
  6.4.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lily Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline
  6.5.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Roche
  6.6.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Roche Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
  6.7.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Merck
  6.8.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merck Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Novartis
  6.9.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Novartis Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Pfizer
  6.10.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Pfizer Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ANTI-INFLAMMATORY DRUGS (NSAIDS) MANUFACTURING COST ANALYSIS

7.1 Anti-Inflammatory Drugs (NSAIDs) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Inflammatory Drugs (NSAIDs)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anti-Inflammatory Drugs (NSAIDs) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Inflammatory Drugs (NSAIDs) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume Forecast by Type (2017-2022)
11.3 United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume Forecast by Application (2017-2022)
11.4 United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Anti-Inflammatory Drugs (NSAIDs)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Market Size (Units) by Type (2012-2022)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume Market Share by Type (Product Category) in 2016
Figure Anti-inflammatory Biologics Product Picture
Figure Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Product Picture
Figure Corticosteroids Product Picture
Figure Others Product Picture
Figure United States Anti-Inflammatory Drugs (NSAIDs) Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Anti-Inflammatory Drugs (NSAIDs) by Application in 2016
Figure Hosptical Examples
Table Key Downstream Customer in Hosptical
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Anti-Inflammatory Drugs (NSAIDs) Market Size (Million USD) by Region (2012-2022)
Figure The West Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2022)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-Inflammatory Drugs (NSAIDs) Sales Share by Players/Suppliers
Figure 2017 United States Anti-Inflammatory Drugs (NSAIDs) Sales Share by Players/Suppliers
Figure United States Anti-Inflammatory Drugs (NSAIDs) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players/Suppliers
Figure 2017 United States Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players/Suppliers
Table United States Market Anti-Inflammatory Drugs (NSAIDs) Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Anti-Inflammatory Drugs (NSAIDs) Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Anti-Inflammatory Drugs (NSAIDs) Market Share of Top 3 Players/Suppliers
Figure United States Anti-Inflammatory Drugs (NSAIDs) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anti-Inflammatory Drugs (NSAIDs) Product Category
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales (Units) by Region (2012-2017)
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales Share by Region (2012-2017)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Share by Region (2012-2017)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region in 2016
Table United States Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Region (2012-2017)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2012-2017)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region in 2016
Table United States Anti-Inflammatory Drugs (NSAIDs) Price (K USD/Unit) by Region (2012-2017)
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales (Units) by Type (2012-2017)
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales Share by Type (2012-2017)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Share by Type (2012-2017)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type in 2016
Table United States Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Inflammatory Drugs (NSAIDs) by Type (2012-2017)
Figure Revenue Market Share of Anti-Inflammatory Drugs (NSAIDs) by Type in 2016
Table United States Anti-Inflammatory Drugs (NSAIDs) Price (K USD/Unit) by Types (2012-2017)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Type (2012-2017)
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales (Units) by Application (2012-2017)
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2012-2017)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2012-2017)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application in 2016
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Application (2012-2017)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Application (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (2012-2017)
Figure AbbVie Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in United States (2012-2017)
Figure AbbVie Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (2012-2017)
Figure Amgen Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in United States (2012-2017)
Figure Amgen Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (2012-2017)
Figure AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in United States (2012-2017)
Figure AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in United States (2012-2017)
Table Eli Lily Basic Information List
Table Eli Lily Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lily Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (2012-2017)
Figure Eli Lily Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in United States (2012-2017)
Figure Eli Lily Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Roche Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (2012-2017)
Figure Roche Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in United States (2012-2017)
Figure Roche Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Merck Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (2012-2017)
Figure Merck Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in United States (2012-2017)
Figure Merck Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (2012-2017)
Figure Novartis Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in United States (2012-2017)
Figure Novartis Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (2012-2017)
Figure Pfizer Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in United States (2012-2017)
Figure Pfizer Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Inflammatory Drugs (NSAIDs)
Figure Manufacturing Process Analysis of Anti-Inflammatory Drugs (NSAIDs)
Figure Anti-Inflammatory Drugs (NSAIDs) Industrial Chain Analysis
Table Raw Materials Sources of Anti-Inflammatory Drugs (NSAIDs) Major Players/Suppliers in 2016
Table Major Buyers of Anti-Inflammatory Drugs (NSAIDs)
Table Distributors/Traders List
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) Forecast by Type in 2022
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) Forecast by Application in 2022
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories